Arcturus Therapeutics
ARCT
Arcturus Therapeutics (ARCT) news
Recent news
Arcturus Therapeutics 2Q loss from ops $25.5M, est. loss $30.1M
AInvest Wire · Aug 6, 2026Arcturus Therapeutics 2Q loss/share 84c vs. loss/share 34c y/y
AInvest Wire · Aug 6, 2026Arcturus Therapeutics strategic pact with Thermo Fisher
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) has previously established strategic partnerships with industry leaders to advance its mRNA-based vaccine and therapeutic development programs. While no direct collaboration between Arcturus and Thermo Fisher Scientific has been disclosed in recent…
AInvest Wire · Jul 2, 2026Arcturus: round led by Initialized Capital with participation from 1517, Breakthrough Energy Discovery, Toyota Ventures, Wireframe Ventures
AInvest Wire · Jun 30, 2026Arcturus: emerges from stealth with $8 mln seed round
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.